• Sutro, Celgene to Refocus 2014 Immuno-Oncology Collaboration americanpharmaceuticalreview
    August 11, 2017
    Sutro Biopharma announced it is refocusing its 2014 immuno-oncology collaboration with Celgene on four programs that are advancing through preclinical development, including an antibody drug conjugate (ADC) program targeting B-Cell maturation antigen (BCM
PharmaSources Customer Service